75N92022F00002↗
Research Triangle Institute received this contract from National Institutes of Health Nhlbi, National Institutes of Health: $46.3K obligated so far for support- professional: other. It runs to 2027-09-29.
Key facts · data as of Oct 28, 2026
- Recipient
- Research Triangle Institute
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Nhlbi (75N920)
- Obligated to date
- $46.3K
- Potential value
- $944.5K
- Ends
- 2027-09-29
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 28, 2026.
Cite this page: SpendQuery, Award 75N92022F00002, data as of Oct 28, 2026, https://spendquery.com/award?id=CONT_AWD_75N92022F00002_7529_75N92022A00005_7529
Research Triangle Institute: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Nhlbi: what it buys · The follow-on: recompete brief
NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - PROJECTS
Up for re-bid: ends 2027-09-29. Recompete brief →
What it is
- Product or service
- Support- Professional: Other (PSC R499)
- Industry
- Administrative Management and General Management Consulting Services (NAICS 541611)
- Contracting office
- National Institutes of Health Nhlbi (75N920)
- Competition
- Full and open competition
- Pricing
- Labor hours
- How it was bought
- Blanket purchase agreement (BPA) · under 75N92022A00005
- Where the work is
- Durham, NC · district NC-04
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
4 subawards totaling $537.6K (1160.2% of what was obligated), as Research Triangle Institute reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Ambiopharm, Inc. | $261.4K | 2 | SC | 2023-12-07 | 2025-06-04 |
| The University of Texas Health Science Center at Tyler | $200.2K | 1 | TX | 2023-12-04 | 2023-12-04 |
| Concord Biosciences, LLC | $76.0K | 1 | OH | 2023-11-17 | 2023-11-17 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2023-12-07 | Ambiopharm, Inc. | $260.1K | SUBCONTRACT 2-312-0218821 INITIAL AWARD DTD 12-7-2023 $492,780 AND MOD 2 (DEOBLIG) DTD 6-4-2025 (232,710.00) = $260,070 |
| 2023-12-04 | The University of Texas Health Science Center at Tyler | $200.2K | SUBCONTRACT 3-312-0218821 INITIAL AWARD |
| 2023-11-17 | Concord Biosciences, LLC | $76.0K | PO C000631169 |
| 2025-06-04 | Ambiopharm, Inc. | $1.3K | 2-312-0218821 MOD 1 |
Every action
6 actions since 2023-05-12. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-08-20 | P00006 | Administrative change | $0 | NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - PROJECTS |
| 2025-09-29 | P00005 | Administrative change | $0 | NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - PROJECTS |
| 2025-05-08 | P00004 | Administrative change | $0 | NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - PROJECTS |
| 2024-09-06 | P00003 | Supplemental agreement (work within scope) | $0 | NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - PROJECTS |
| 2023-09-26 | P00002 | Administrative change | $0 | NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - PROJECTS |
| 2023-05-12 | P00001 | Funding only | $46.3K | NHLBI CATALYZE PROGRAM - PRECLINICAL SERVICES COMPONENT - PROJECTS |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-28). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗